Trials / Terminated
TerminatedNCT01541813
Rare Iron Overloads Except C282Y Homozygosity : Description and Characterization.
Clinical, Biological, Genetic and Functional Characterization of Rare Iron Overload Phenotypes Associated With Hepcidin Deficiency Except C282Y Homozygosity.
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 62 (actual)
- Sponsor
- Rennes University Hospital · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Chronic iron overload is responsible for morbidity and mortality. There are many genetic and acquired causes. One of them is an hepcidin deficiency. Hepcidin is the regulating hormone for iron. The study explores this specific cause, and aim to characterize this iron overload in term of clinical, biological, genetic and functional specificities.
Detailed description
One of chronic iron overload profiles is a deficit in hepcidin. Hepcidin is the regulating hormone for iron. This specific profile is characterized by an elevated serum iron, an elevated transferrin saturation, and parenchymal damages of iron overload. This disease is not connected with known mutations of iron metabolism genes. The main objective of this study is the clinical, biological, genetic and functional characterization of rare iron overload phenotypes associated with hepcidin deficiency except C282Y homozygosity.
Conditions
Timeline
- Start date
- 2011-03-01
- Primary completion
- 2014-08-01
- Completion
- 2014-12-01
- First posted
- 2012-03-01
- Last updated
- 2015-03-10
Locations
10 sites across 1 country: France
Source: ClinicalTrials.gov record NCT01541813. Inclusion in this directory is not an endorsement.